A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration

Tivadar Orban1, Henri Leinonen1, Tamar Getter1

  • 1Department of Pharmacology, Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, Ohio (T.O., H.L., T.G., S.G., A.V., H.H.-T., T.S.K., P.D.K., K.P.); Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio (T.S.K., P.D.K.); and Polgenix Inc., Cleveland, Ohio (Z.D., W.S.).

Insights

This study shows a combination therapy using metoprolol, tamsulosin, and bromocriptine can protect cone cells, crucial for vision, from retinal degeneration. This approach offers potential for treating genetic and age-related eye diseases.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Genetics

Background:

  • Retinal degenerative diseases affect photoreceptor cells, retinal pigment epithelium (RPE), neurons, and glial cells.
  • Cone cells, vital for daily activity, are often impacted in retinal degeneration.
  • Existing treatments for retinal degeneration are limited, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the protective effects of a combination therapy involving metoprolol, tamsulosin, and bromocriptine on cone cells.
  • To evaluate the safety and efficacy of this drug combination in a preclinical model of retinal degeneration.
  • To determine the ocular penetration and target engagement of the therapeutic agents.

Main Methods:

  • Testing a combination therapy of metoprolol, tamsulosin, and bromocriptine in *Abca4* mice, a model for retinal degeneration.
  • Assessing drug specificity against a comprehensive panel of human G protein-coupled receptors.
  • Evaluating electroretinographic responses in wild-type mice to determine safety.
  • Utilizing RNA sequencing and quantitative PCR to confirm target gene expression in ocular tissues.
  • Employing liquid chromatography-mass spectrometry to quantify drug levels in the eye following administration.

Main Results:

  • The combination therapy demonstrated protective effects on cone cells in the *Abca4* mouse model.
  • The drugs showed specificity for their G protein-coupled receptor targets.
  • No adverse effects on electroretinographic responses were observed in wild-type mice.
  • Metoprolol, tamsulosin, and bromocriptine were confirmed to penetrate ocular tissues after systemic administration.
  • Target receptors were found to be expressed in both human and mouse eyes.

Conclusions:

  • The combination of metoprolol, tamsulosin, and bromocriptine shows promise for protecting cone cells against retinal degeneration.
  • This therapy is a potential candidate for human clinical trials to treat genetic retinal diseases like Stargardt disease.
  • The low-dose combination may also offer protection against age-related macular degeneration and other complex retinal conditions.

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
9.5K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.3K
Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
3.3K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.8K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
17.9K
Photoreceptors and Plant Responses to Light02:00

Photoreceptors and Plant Responses to Light

Light plays a significant role in regulating the growth and development of plants. In addition to providing energy for photosynthesis, light provides other important cues to regulate a range of developmental and physiological responses in plants.
28.6K